These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22553460)

  • 21. Microarray analysis of the differential transformation mediated by Kirsten and Harvey Ras oncogenes in a human colorectal adenocarcinoma cell line.
    Roberts ML; Drosopoulos KG; Vasileiou I; Stricker M; Taoufik E; Maercker C; Guialis A; Alexis MN; Pintzas A
    Int J Cancer; 2006 Feb; 118(3):616-27. PubMed ID: 16152623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effect of mutant and wild-type p53 on global gene expression.
    O'Farrell TJ; Ghosh P; Dobashi N; Sasaki CY; Longo DL
    Cancer Res; 2004 Nov; 64(22):8199-207. PubMed ID: 15548685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of tumorigenesis by the p53 target PUMA.
    Hemann MT; Zilfou JT; Zhao Z; Burgess DJ; Hannon GJ; Lowe SW
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9333-8. PubMed ID: 15192153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allele specific gain-of-function activity of p53 mutants in lung cancer cells.
    Vaughan CA; Frum R; Pearsall I; Singh S; Windle B; Yeudall A; Deb SP; Deb S
    Biochem Biophys Res Commun; 2012 Nov; 428(1):6-10. PubMed ID: 22989750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
    Halaschek-Wiener J; Wacheck V; Schlagbauer-Wadl H; Wolff K; Kloog Y; Jansen B
    Mol Med; 2000 Aug; 6(8):693-704. PubMed ID: 11055588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.
    Tseng YS; Lee JC; Huang CY; Liu HS
    BMC Cancer; 2009 Dec; 9():435. PubMed ID: 20003375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
    Delgado MD; Vaqué JP; Arozarena I; López-Ilasaca MA; Martínez C; Crespo P; León J
    Oncogene; 2000 Feb; 19(6):783-90. PubMed ID: 10698496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1).
    Kloet DE; Polderman PE; Eijkelenboom A; Smits LM; van Triest MH; van den Berg MC; Groot Koerkamp MJ; van Leenen D; Lijnzaad P; Holstege FC; Burgering BM
    Biochem J; 2015 Jul; 469(2):289-98. PubMed ID: 25990325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.
    Bigi A; Beltrami E; Trinei M; Stendardo M; Pelicci PG; Giorgio M
    Oncogene; 2016 Sep; 35(39):5132-43. PubMed ID: 26973251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor p53 and its gain-of-function mutants in cancer.
    Liu J; Zhang C; Feng Z
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):170-9. PubMed ID: 24374774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.
    Lu X; Liu DP; Xu Y
    Oncogene; 2013 Jun; 32(23):2900-6. PubMed ID: 22824795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase.
    Kachnic LA; Wu B; Wunsch H; Mekeel KL; DeFrank JS; Tang W; Powell SN
    J Biol Chem; 1999 May; 274(19):13111-7. PubMed ID: 10224064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.
    Labalette C; Nouët Y; Levillayer F; Armengol C; Renard CA; Soubigou G; Xia T; Buendia MA; Wei Y
    PLoS One; 2008; 3(11):e3761. PubMed ID: 19018287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.
    Boiko AD; Porteous S; Razorenova OV; Krivokrysenko VI; Williams BR; Gudkov AV
    Genes Dev; 2006 Jan; 20(2):236-52. PubMed ID: 16418486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.